Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J Pumps MedTech Growth; Offers $16.6BN+ For Abiomed

Nov 02 2022

• By Reed Miller

Abiomed’s Impella 5.0 Heart Pump Transcatheter Circulatory Support Device — Abiomed's Impella Circulatory Support Device • Source: Abiomed

Related Content

JPM 2022: Abiomed, Penumbra, Renalityx

Jan 14 2022

Cordis Makes First Big Post-Cardinal Deal: Agrees To Pay $1.1BN For MedAlliance

Oct 18 2022

Abiomed Acquires German Micro-Pump Maker Impella for Nearly $75 mil.

May 02 2005

J&J Pushes Back Launch Of Ottava Robotic Platform By Two Years

Oct 20 2021

J&J To Split Consumer From Medtech and Pharmaceutical Businesses – Creating Two Companies To Unlock More Value, Growth, Innovation

Nov 12 2021

Abiomed Manages Pandemic Recovery By Moving Operations Online

Aug 10 2020

Exec Chat: Biosense Webster Is Ready For Next Chapters Of The Electrophysiology Story

Jun 13 2022

Series B Pumps $15m Into Abiomed-Backed Acute HF Start-Up

Sep 28 2017

Related Companies

Johnson & Johnson

Abiomed, Inc.

Biosense Webster Inc

Cordis Corp.

Codman Neuro

LifeScan Inc.

Boston Scientific Corporation

Cardiovascular Systems, Inc.

Magenta Medical Ltd.

Additional Topics

Approvals Commercial Business Strategies Companies M & A Cardiovascular Cardiology Medical Device

More from Approvals

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window